Cardinal Health reported $25 million in total pay for CEO Jason Hollar (up 37%) and said pay for its median worker dropped 19 ...
Zacks Investment Research on MSN3d
CAH Stock Up Nearly 7% This Year: Is Now the Time to Buy?Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and ...
From the fiscal third quarter of 2024, Cardinal Health started reporting its results under new operating segments — Pharmaceutical and Specialty solutions, Global Medical Products and ...
China was the leading supplier of N95 masks and other respirators for healthcare in 2023 and provided approximately 33% of ...
Robert Musslewhite and Sudhakar Ramakrishna are joining Cardinal Health's board of directors. Cardinal Health’s board of ...
Hosted on MSN1mon
Jefferies Upgrades Cardinal Health (CAH)Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare ...
Hosted on MSN1mon
Cardinal Health (NYSE:CAH) Beats Q4 Sales TargetsOver the last two years, Cardinal Health’s Pharmaceutical revenue revenue () averaged 8% year-on-year growth while its Medical revenue ... and suggests its newer products and services will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback